Clinical Study

Optimal Keratoplasty for the Correction of Presbyopia and Hypermetropia

Table 2

Visual acuity outcomes.

Baseline1 hour1 day1 week1 month3 months6 monthsSignificance

All eyesMonocular UNVA
logMAR ± SD
(Snellen)
0.58 ± 0.19
(20/76)
0.22 ± 0.13
(20/33)
0.24 ± 0.13
(20/35)
0.31 ± 0.14
(20/41)
0.32 ± 0.14
(20/42)
0.31 ± 0.16
(20/41)
0.34 ± 0.15
(20/44)
value
Binocular UNVA
logMAR ± SD
(Snellen)
0.49 ± 0.16
(20/62)
0.15 ± 0.1
(20/28)
0.17 ± 0.11
(20/30)
0.25 ± 0.13
(20/36)
0.24 ± 0.11
(20/35)
0.24 ± 0.13
(20/35)
0.29 ± 0.12
(20/39)
value

Double-treated eyesMonocular UNVA
logMAR ± SD
(Snellen)
0.60 ± 0.21
(20/80)
0.30 ± 0.21
(20/40)
0.27 ± 0.20
(20/37)
0.34 ± 0.16
(20/44)
0.39 ± 0.17
(20/49)
0.30 ± 0.18
(20/40)
0.32 ± 0.17
(20/42)
value
Binocular UNVA
logMAR ± SD
(Snellen)
0.51 ± 0.22
(20/65)
0.17 ± 0.15
(20/30)
0.19 ± 0.15
(20/31)
0.28 ± 0.15
(20/38)
0.30 ± 0.17
(20/40)
0.25 ± 0.16
(20/36)
0.28 ± 0.17
(20/38)
value

Hypermetropic/presbyopic eyesMonocular UDVA
logMAR ± SD
(Snellen)
0.41 ± 0.19
(20/51)
0.13 ± 0.1
(20/27)
0.12 ± 0.11
(20/26)
0.15 ± 0.13
(20/28)
0.14 ± 0.12
(20/28)
0.14 ± 0.12
(20/28)
0.16 ± 0.12
(20/29)
value
Binocular UDVA
logMAR ± SD
(Snellen)
0.28 ± 0.13
(20/38)
0.06 ± 0.07
(20/23)
0.04 ± 0.1
(20/22)
0.06 ± 0.09
(20/23)
0.09 ± 0.1
(20/25)
0.11 ± 0.1
(20/26)
0.13 ± 0.1
(20/27)
value

Pure presbyopic eyesMonocular UDVA
logMAR ± SD
(Snellen)
0.04 ± 0.02
(20/22)
0 ± 0.04
(20/20)
0.03 ± 0.06
(20/21)
0.04 ± 0.1
(20/22)
0 ± 0.05
(20/20)
0 ± 0.04
(20/20)
0.03 ± 0.06
(20/21)
value
Binocular UDVA
logMAR ± SD
(Snellen)
0 ± 0.05
(20/20)
−0.04 ± 0.06
(20/20)
−0.03 ± 0.05
(20/20)
0 ± 0.1
(20/20)
−0.06 ± 0.06
(20/18)
−0.05 ± 0.05
(20/18)
−0.04 ± 0.06
(20/20)
value

Patient satisfaction for near activities33 ± 2076 ± 2071 ± 2075 ± 1968 ± 1671 ± 16
value

Patient satisfaction for distance activities70 ± 2382 ± 1082 ± 1484 ± 1487 ± 1184 ± 14
value

UNVA: uncorrected near visual acuity; UDVA: uncorrected distance visual acuity.